Durvalumab

Status:
Do Not Prescribe (DNP), Red
Decision Date:
June 2019
 

Comments

RED: NICE TA578 - Locally advanced, unresectable non-small cell lung cancer after platinum-based chemoradiation. (Decision date - June 2019)

DO NOT PRESCRIBE (DNP): NICE TA662 - in combination for untreated extensive-stage small cell lung cancer (Terminated appraisal) (Decision date - December 2020) 

Red Drug Classifications

  • 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again

Derby and Derbyshire CCG

Derby and Derbyshire CCG